{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T10:13:08Z","timestamp":1763201588800},"reference-count":35,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Peptides"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1016\/j.peptides.2010.04.026","type":"journal-article","created":{"date-parts":[[2010,5,8]],"date-time":"2010-05-08T10:00:29Z","timestamp":1273312829000},"page":"1523-1530","source":"Crossref","is-referenced-by-count":14,"title":["Chronic urotensin II receptor antagonist treatment does not alter hypertrophy or fibrosis in a rat model of pressure-overload hypertrophy"],"prefix":"10.1016","volume":"31","author":[{"given":"Andrew R.","family":"Kompa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bing H.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arintaya","family":"Phrommintikul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei Y.","family":"Ho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darren J.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Behm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen A.","family":"Douglas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henry","family":"Krum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.peptides.2010.04.026_bib1","doi-asserted-by":"crossref","first-page":"H2797","DOI":"10.1152\/ajpheart.2000.279.6.H2797","article-title":"Renin-angiotensin system and sympathetic nervous system in cardiac pressure-overload hypertrophy","volume":"279","author":"Akers","year":"2000","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.peptides.2010.04.026_bib2","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/45809","article-title":"Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14","volume":"401","author":"Ames","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.peptides.2010.04.026_bib3","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/bjp.2008.266","article-title":"Palosuran inhibits binding to primate UT receptors in cell membranes but demonstrates differential activity in intact cells and vascular tissues","volume":"155","author":"Behm","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.peptides.2010.04.026_bib4","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.yjmcc.2006.05.008","article-title":"Urotensin-II blockade with SB-611812 attenuates cardiac dysfunction in a rat model of coronary artery ligation","volume":"41","author":"Bousette","year":"2006","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.peptides.2010.04.026_bib5","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1016\/j.peptides.2006.06.011","article-title":"Urotensin-II receptor blockade with SB-611812 attenuates cardiac remodeling in experimental ischemic heart disease","volume":"27","author":"Bousette","year":"2006","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2010.04.026_bib6","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1097\/01.hjh.0000125452.28861.f1","article-title":"Plasma concentration of urotensin II is raised in hypertension","volume":"22","author":"Cheung","year":"2004","journal-title":"J Hypertens"},{"key":"10.1016\/j.peptides.2010.04.026_bib7","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/sj.bjp.0706229","article-title":"Nonpeptidic urotensin-II receptor antagonists I: in vitro pharmacological characterization of SB-706375","volume":"145","author":"Douglas","year":"2005","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.peptides.2010.04.026_bib8","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1016\/S0140-6736(02)08831-1","article-title":"Congestive heart failure and expression of myocardial urotensin II","volume":"359","author":"Douglas","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.peptides.2010.04.026_bib9","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/S0002-8703(97)70230-8","article-title":"Differential changes in sympathetic activity in left and right ventricles in congestive heart failure after myocardial infarction","volume":"133","author":"Ganguly","year":"1997","journal-title":"Am Heart J"},{"key":"10.1016\/j.peptides.2010.04.026_bib10","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/j.peptides.2007.04.018","article-title":"Hemodynamic effects of chronic urotensin II administration in animals with and without aorto-caval fistula","volume":"28","author":"Harris","year":"2007","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2010.04.026_bib11","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.peptides.2009.02.009","article-title":"Increased expression of urotensin II, urotensin II-related peptide and urotensin II receptor mRNAs in the cardiovascular organs of hypertensive rats: comparison with endothelin-1","volume":"30","author":"Hirose","year":"2009","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2010.04.026_bib12","first-page":"H1818","article-title":"Active renin and angiotensinogen in cardiac interstitial fluid after myocardial infarction","volume":"276","author":"Hirsch","year":"1999","journal-title":"Am J Physiol"},{"key":"10.1016\/j.peptides.2010.04.026_bib13","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1124\/jpet.107.133546","article-title":"Long-term but not short-term p38 mitogen-activated protein kinase inhibition improves cardiac function and reduces cardiac remodeling post-myocardial infarction","volume":"325","author":"Kompa","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.peptides.2010.04.026_bib14","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1016\/j.peptides.2004.03.029","article-title":"Cardiovascular role of urotensin II: effect of chronic infusion in the rat","volume":"25","author":"Kompa","year":"2004","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2010.04.026_bib15","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1097\/00005344-200204000-00016","article-title":"Tissue angiotensin-converting enzyme activity plays an important role in pressure overload-induced cardiac fibrosis in rats","volume":"39","author":"Kurosawa","year":"2002","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.peptides.2010.04.026_bib16","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1161\/01.CIR.0000121326.69153.98","article-title":"Differential effect of urotensin II on vascular tone in normal subjects and patients with chronic heart failure","volume":"109","author":"Lim","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.peptides.2010.04.026_bib17","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1016\/j.peptides.2004.01.028","article-title":"Cellular distribution of immunoreactive urotensin-II in human tissues with evidence of increased expression in atherosclerosis and a greater constrictor response of small compared to large coronary arteries","volume":"25","author":"Maguire","year":"2004","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2010.04.026_bib18","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1291\/hypres.26.89","article-title":"Angiotensin II type 2 receptor blockade partially negates antihypertrophic effects of type 1 receptor blockade on pressure-overload rat cardiac hypertrophy","volume":"26","author":"Mukawa","year":"2003","journal-title":"Hypertens Res"},{"key":"10.1016\/j.peptides.2010.04.026_bib19","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.peptides.2007.12.018","article-title":"Increased gene expression of urotensin II-related peptide in the hearts of rats with congestive heart failure","volume":"29","author":"Nakayama","year":"2008","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2010.04.026_bib20","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.atherosclerosis.2008.10.044","article-title":"Targeted overexpression of the human urotensin receptor transgene in smooth muscle cells: effect of UT antagonism in ApoE knockout mice fed with Western diet","volume":"204","author":"Papadopoulos","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.peptides.2010.04.026_bib21","doi-asserted-by":"crossref","first-page":"H1804","DOI":"10.1152\/ajpheart.01078.2007","article-title":"Effects of a Rho kinase inhibitor on pressure overload induced cardiac hypertrophy and associated diastolic dysfunction","volume":"294","author":"Phrommintikul","year":"2008","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.peptides.2010.04.026_bib22","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0140-6736(02)09709-X","article-title":"Plasma urotensin II in heart failure","volume":"360","author":"Richards","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.peptides.2010.04.026_bib23","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1525-1594.2004.47350.x","article-title":"Echocardiographic assessment of global ventricular function using the myocardial performance index in rats with hypertrophy","volume":"28","author":"Salemi","year":"2004","journal-title":"Artif Organs"},{"key":"10.1016\/j.peptides.2010.04.026_bib24","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0894-7317(89)80014-8","article-title":"Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms","volume":"2","author":"Schiller","year":"1989","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.peptides.2010.04.026_bib25","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1253\/circj.66.1168","article-title":"Left and right coronary circulation in left ventricular hypertrophy: effects of angiotensin converting enzyme inhibition","volume":"66","author":"Shimada","year":"2002","journal-title":"Circ J"},{"key":"10.1016\/j.peptides.2010.04.026_bib26","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1093\/cvr\/24.9.741","article-title":"Reactive and reparative fibrillar collagen remodelling in the hypertrophied rat left ventricle: two experimental models of myocardial fibrosis","volume":"24","author":"Silver","year":"1990","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.peptides.2010.04.026_bib27","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.amjhyper.2005.03.748","article-title":"Effect of exogenous urotensin-II on vascular tone in skin microcirculation of patients with essential hypertension","volume":"18","author":"Sondermeijer","year":"2005","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.peptides.2010.04.026_bib28","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.bbrc.2003.09.102","article-title":"Identification of urotensin II-related peptide as the urotensin II-immunoreactive molecule in the rat brain","volume":"310","author":"Sugo","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.peptides.2010.04.026_bib29","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0024-3205(02)02346-9","article-title":"Urotensin II-induced activation of extracellular signal-regulated kinase in cultured vascular smooth muscle cells: involvement of cell adhesion-mediated integrin signaling","volume":"72","author":"Tamura","year":"2003","journal-title":"Life Sci"},{"key":"10.1016\/j.peptides.2010.04.026_bib30","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0008-6363(98)00156-4","article-title":"Pulmonary and cardiac expression of preproendothelin-1 mRNA are increased in heart failure after myocardial infarction in rats. Localization of preproendothelin-1 mRNA and endothelin peptide","volume":"39","author":"Tonnessen","year":"1998","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.peptides.2010.04.026_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/CS20020271","article-title":"Increased plasma urotensin II levels in patients with diabetes mellitus","volume":"104","author":"Totsune","year":"2003","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.peptides.2010.04.026_bib32","doi-asserted-by":"crossref","first-page":"H608","DOI":"10.1152\/ajpheart.00942.2009","article-title":"Chronic urotensin-II infusion induces diastolic dysfunction and enhances collagen production in rats","volume":"298","author":"Tran","year":"2010","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.peptides.2010.04.026_bib33","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1161\/01.RES.0000084382.64418.BC","article-title":"Direct actions of urotensin II on the heart: implications for cardiac fibrosis and hypertrophy","volume":"93","author":"Tzanidis","year":"2003","journal-title":"Circ Res"},{"key":"10.1016\/j.peptides.2010.04.026_bib34","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1161\/01.CIR.103.1.155","article-title":"Reduction in myocardial collagen cross-linking parallels left ventricular dilatation in rat models of systolic chamber dysfunction","volume":"103","author":"Woodiwiss","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.peptides.2010.04.026_bib35","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0014-5793(01)03015-0","article-title":"Urotensin II induces hypertrophic responses in cultured cardiomyocytes from neonatal rats","volume":"508","author":"Zou","year":"2001","journal-title":"FEBS Lett"}],"container-title":["Peptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978110001804?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978110001804?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T02:23:31Z","timestamp":1559096611000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196978110001804"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":35,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["S0196978110001804"],"URL":"https:\/\/doi.org\/10.1016\/j.peptides.2010.04.026","relation":{},"ISSN":["0196-9781"],"issn-type":[{"value":"0196-9781","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8]]}}}